id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-D-1143-0099,FDA,FDA-2013-D-1143,"Use of Nucleic Acid Tests To Reduce the Risk of Transmission of West Nile
Virus From Living Donors of Human Cells, Tissues, and Cellular and
Tissue-Based Products; Guidance for Industry; Correction",Notice,Correction,2016-09-29T04:00:00Z,2016,9,2016-09-29T04:00:00Z,,2016-09-29T15:15:04Z,2016-23514,0,0,090000648227f819
FDA-2013-D-1143-0097,FDA,FDA-2013-D-1143,"Use of Nucleic Acid Tests To Reduce the Risk of Transmission of West Nile
Virus From Living Donors of Human Cells, Tissues, and Cellular and
Tissue-Based Products; Guidance for Industry; Availability",Notice,Notice of Availability,2016-09-13T04:00:00Z,2016,9,2016-09-13T04:00:00Z,2016-12-13T04:59:59Z,2016-09-13T14:43:16Z,2016-21969,0,0,0900006482202771
FDA-2013-D-1143-0098,FDA,FDA-2013-D-1143,"Use of Nucleic Acid Tests to Reduce the Risk of Transmission of West Nile Virus from Living Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps); Guidance for Industry",Other,Guidance,2016-09-08T04:00:00Z,2016,9,2016-09-08T04:00:00Z,,2024-11-07T23:49:39Z,,1,0,09000064821e37f2